0001240679-17-000035.txt : 20170906 0001240679-17-000035.hdr.sgml : 20170906 20170906163401 ACCESSION NUMBER: 0001240679-17-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170901 FILED AS OF DATE: 20170906 DATE AS OF CHANGE: 20170906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHAFFER MICHAEL I CENTRAL INDEX KEY: 0001250730 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13738 FILM NUMBER: 171071720 MAIL ADDRESS: STREET 1: C/O PAYCHEMEDICS CORP STREET 2: 1280 MASSACHUSETTS AVE STE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-206-8220 MAIL ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-09-01 0000806517 PSYCHEMEDICS CORP PMD 0001250730 SCHAFFER MICHAEL I C/O PSYCHEMEDICS CORPORATION 125 NAGOG PARK ACTON MA 01720 0 1 0 0 VP of Laboratory Operations Common Stock, $.005 Par Value 2017-09-01 4 S 0 981 21.16 D 41273 D Common Stock, $.005 Par Value 2017-09-05 4 S 0 4400 20.37 D 36873 D Common Stock, $.005 Par Value 2017-09-06 4 S 0 2167 20.14 D 34706 D The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.22, inclusive. The reporting person undertakes to provide to Psychemedics Corp., any security holder of Psychemedics Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.26 to $20.54, inclusive. The reporting person undertakes to provide to Psychemedics Corp., any security holder of Psychemedics Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Includes an additional 188 shares acquired since May 23, 2017 under the Company's Dividend Reinvestment Plan. Patrick J. Kinney, Jr. as attorney-in-fact for Michael I. Schaffer 2017-09-06